Article
Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing.
American journal of clinical pathology - 1 Apr 2014
Portier Bryce P, Kanagal-Shamanna Rashmi, Luthra Rajyalakshmi, Singh Rajesh, Routbort Mark J, Handal Brian, Reddy Neelima, Barkoh Bedia A, Zuo Zhuang, Medeiros L Jeffrey, Aldape Kenneth, Patel Keyur P
Abstract excerpt
OBJECTIVES: Identification of tumor-specific somatic mutations has had a significant impact on both disease diagnosis and therapy selection. The ability of next-generation sequencing (NGS) to provide a quantitative assessment of mutant allele burden, in numerous target genes in a single assay, provides a significant advantage over conventional qualitative genotyping platforms. METHODS: We assessed the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
